文献速递外周动脉疾病

对糖尿病患者足部溃疡中外周动脉疾病诊断、预后和管理证据质量的批判性评价

Critical Appraisal of the Quality of Evidence Addressing the Diagnosis, Prognosis, and Management of Peripheral Artery Disease in Patients With Diabetic Foot Ulceration.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-06-13

本研究使用国际糖尿病足工作组与欧洲伤口管理协会发布的21分疾病特异性研究评价工具(TOPS),评价2015年IWGDF指南中关于糖尿病患者足部溃疡(DFU)患者外周动脉疾病(PAD)诊断、预后和管理研究的质量。共纳入研究的总分中位数为8分(范围3-12/21),设计、实施和结局报告的中位得分分别为2分(0-4/11)、2分(1-4/6)和3分(1-4/4)。随时间推移,总分、设计总分和结局总分均有改善,但实施总分无改善。

要点

  • 使用TOPS工具评价DFU患者PAD相关研究的质量,总分中位数仅8/21。
  • 研究设计得分中位数2/11,实施得分中位数2/6,结局报告得分中位数3/4。
  • 总分、设计总分和结局总分随时间改善,实施总分未改善。

核心结论

  • 尽管分析显示研究总体质量随时间有所改善,但目前证据质量仍较差,不足以指导PAD合并DFU患者的诊断、管理和预后。

研究设计与样本

  • 基于2015年IWGDF关于DFU患者PAD诊断、预后和管理的指南识别相关研究,由两名评价者使用TOPS工具(21分,评价研究设计、实施和结局报告)进行评价。

主要发现

  • 总体中位评分为8分(范围3-12/21)。
  • 设计总分中位评分为2分(范围0-4/11)。
  • 实施总分中位评分为2分(范围1-4/6)。
  • 结局总分中位评分为3分(范围1-4/4)。
  • 总体总分(Spearman Rho 0.39,p = .0005)、设计总分(0.35,p = .0023)和结局总分(0.35,p = .0002)随时间改善,但实施总分(-0.03,p = .8132)未随时间改善。

关键数值与推荐

  • TOPS工具共21分,其中设计部分11分,实施部分6分,结局报告部分4分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: There is a paucity of robust evidence on prevention and management of diabetic foot ulcers (DFUs) to inform treatment. This study appraises the current quality of the evidence addressing diagnosis, prognosis, and management of peripheral artery disease (PAD) in patients with DFUs using a newly devised 21 point scoring (TOPS) disease specific research appraisal tool published by the International Working Group on the Diabetic Foot (IWGDF) and European Wound Management Association. METHODS: The 2015 IWGDF guidance on diagnosis, prognosis, and management of PAD in patients with DFUs was used to identify studies pertaining to prevention and management. Two reviewers assessed these articles against TOPS, which examines study design, conduct, and outcome reporting. RESULTS: The overall median score was 8 (3-12/21). The median design total score was 2 (0-4/11). The median conduct total score was 2 (1-4/6). The median outcomes total score was 3 (1-4/4). There was improvement with time in overall total (Spearman Rho 0.39, p = .0005), design total (0.35, p = .0023), and outcomes total (0.35, p = .0002), but not conduct total (-0.03, p = .8132) scores. CONCLUSIONS: Although this analysis revealed an improvement over time in the overall calibre of studies, the present quality remains poor on which to inform the diagnosis, management, and prognosis of patients with PAD and diabetic foot ulceration.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ali SR, Ozdemir BA, Hinchliffe RJ, et al. Critical Appraisal of the Quality of Evidence Addressing the Diagnosis, Prognosis, and Management of Peripheral Artery Disease in Patients With Diabetic Foot Ulceration. Eur J Vasc Endovasc Surg. 2018. PMID: 29909087. doi:10.1016/j.ejvs.2018.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。